Fifteen patients receiving an experimental stem cell therapy to treat advanced MS didn’t have the expected deteroriation in their condition.
- Professor of Regenerative Neuroimmunology, University of Cambridge
Contact Stefano for
- General
- Media request
- Speaking request
- Consulting / Advising
- Research collaboration
- Research supervision
- Article Feed
- Joined
